ASML’s valuation has risen to about $700bn (€600bn), making it Europe’s most valuable listed business, reflecting strong investor confidence in its leading chipmaking technology. The article suggests that chatter about a next “round number” for its market value no longer feels fanciful, implying continued positive sentiment despite the focus on longer-term growth rather than a specific new earnings or policy catalyst.
The move is less about this quarter and more about the market assigning ASML a longer monopoly duration. That can keep the multiple elevated, but it also turns the stock into a high-beta proxy for a very small set of end-markets: TSMC, Samsung, Intel, and China-adjacent demand that can disappear quickly if export controls tighten. In practice, that means the next leg higher likely requires evidence that advanced-node capex is still accelerating, not just enthusiasm around AI.
Relative winners are the foundry leaders that can actually absorb ASML’s tools and convert them into pricing power; relative losers are equipment peers that rely on the same broad semiconductor spending wave but do not have ASML’s bottleneck economics. Second-order, a richer ASML can crowd capital away from other European industrials and amplify index concentration risk in Europe, which matters because passive flows can become a source of instability if guidance disappoints. If order intake or backlog growth slows, the rerating can reverse faster than the fundamental cycle because the stock now trades as a scarcity asset.
The main contrarian point is that consensus may be confusing structural importance with linear growth. Lithography intensity per wafer is not guaranteed to rise forever, and AI spend can shift toward architectures that grow compute dollars without proportionally increasing ASML’s unit demand. Over 1-3 months, watch commentary on 2026-2027 capacity and China restrictions; over 6-18 months, the falsifier is a flat TSMC capex path or any delay in High-NA ramp economics.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment